Skip to main content

Consumer

By Nathan Eddy | 02:35 pm | February 26, 2026
The platform uses wearable biometric data and clinician-reviewed medical research to provide guidance on menstrual-, pregnancy- and menopause-related health.
By Jessica Hagen | 01:43 pm | February 26, 2026
The program connects self-pay patients with clinicians to access GLP-1s, including Wegovy, starting at $149 per month, with no subscription fee.
By Jessica Hagen | 12:34 pm | February 19, 2026
The smartwatch is built for extreme environments and includes heart rate, sleep, blood oxygen and stress monitoring.
By Jessica Hagen | 12:30 pm | February 16, 2026
CMS Administrator Dr. Mehmet Oz said AI avatars could support early mental health intakes and flag subtle cues alongside clinical oversight.
By Jessica Hagen | 08:00 am | February 11, 2026
The partnership will allow Mira's hormone test results to be compared with Oura Ring data on sleep, temperature and readiness, enabling trend tracking.
By Jessica Hagen | 04:22 pm | February 04, 2026
The company was granted a preliminary injunction blocking U.S. sales of an alleged copycat fitness tracker by Chinese company Shenzhen Lexqi Electronic Technology Co.
By Jessica Hagen | 12:46 pm | January 23, 2026
The situation marked a rare medical emergency that prompted an early return from the ISS, highlighting how crews manage serious health events in space.
By Jessica Hagen | 11:15 am | January 09, 2026
The digital pharmacy will sell the newly FDA-approved weight-loss pill nationwide, allowing patients to pay through their insurance or in cash.
By Susan Morse | 05:25 pm | November 21, 2025
As chair of the Public Health and Environment Committee, Baltimore Councilwoman Phylicia Porter helps direct local policy and legislation on health disparities.
By Jessica Hagen | 03:01 pm | November 06, 2025
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.